Enavate secures $300m from Patient Square
Patient Square Capital has invested $300 million in its newly formed company Enavate Sciences, a platform focused on growing therapeutic companies.
2 May 2022•3 mins read
Patient Square Capital has invested $300 million in its newly formed company Enavate Sciences, a platform focused on growing therapeutic companies.
Covalent Equity Partners backs anti-money laundering testing firm AML Analytics
24 minutes ago · 2 mins read
Falfurrias-backed Oddball makes first add-on with Synaptic Era Salesforce deal
30 minutes ago · 1 min read
Aldrich Capital Partners backs claims cost containment firm TempusDirect
34 minutes ago · 2 mins read
Ridgeview Partners completes acquisition of automotive software provider Pinewood Technologies Group
38 minutes ago · 1 min read
Riverwood Capital inks $730m sale of Vexcel to CoStar Group
42 minutes ago · 2 mins read
Orangewood forms THRM foodservice platform, acquires RSG in first investment
1 hour ago · 3 mins read
Triton agrees $9.0bn sale of Trench Group to GE Vernova
1 hour ago · 2 mins read
